NRG1271 is an orally active mitochondrial permeability transition pore ( mPTP ) inhibitor with blood-brain barrier penetration. NRG1271 can be used for the study of Neurological Disease .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Mitochondrial Metabolism
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.